Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin type B (Myobloc).

Leslie Baumann1, Laura Black

  • 1Division of Cosmetic Dermatology, University of Miami, Miami, Florida, USA.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|May 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study.

The Lancet. Respiratory medicine·2026
Same author

Long-term Safety and Effectiveness of Cold-Crosslinked Hyaluronic Acid Fillers: Multicenter, Randomized, Controlled, Double-Blind Study.

Aesthetic surgery journal·2025
Same author

Incorporating value-informed advanced nursing practice into APRN education.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing·2025
Same author

Improvement in Temple Hollowing with VYC-20L Hyaluronic Acid Filler: A Multicenter Randomized Controlled Trial of Safety and Effectiveness.

Plastic and reconstructive surgery·2025
Same author

Physical and Environmental Barriers to Mobility and Participation in Children With Medical Complexity: A Qualitative Study.

Clinical pediatrics·2022
Same author

Erasmus Wilson's role in soap advertisements: Cleansing a soiled reputation.

Clinics in dermatology·2021

Botulinum toxin type B, including Myobloc and Neurobloc, has various therapeutic uses. This review examines the known efficacy and safety of botulinum toxin type B, despite its non-cosmetic approval.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Myobloc, also known as Neurobloc in Europe, is a botulinum toxin type B formulation.
  • Approved in the US in 2000, it has been utilized for diverse medical conditions.
  • While not FDA-approved for cosmetic applications, it has been used off-label for such purposes.

Purpose of the Study:

  • To provide a comprehensive review of botulinum toxin type B.
  • To summarize current knowledge regarding its efficacy across various indications.
  • To assess the safety profile of botulinum toxin type B.

Main Methods:

  • Literature review of existing studies and clinical data.
  • Analysis of published research on botulinum toxin type B.
  • Synthesis of information on efficacy and safety data.

Related Experiment Videos

Main Results:

  • Botulinum toxin type B demonstrates efficacy in several therapeutic areas.
  • Safety data indicates a manageable adverse event profile.
  • Off-label cosmetic use has been reported, but is not an approved indication.

Conclusions:

  • Botulinum toxin type B is a valuable therapeutic agent with a defined efficacy and safety.
  • Further research may clarify its role in both approved and unapproved indications.
  • Understanding its properties is crucial for appropriate clinical application.